Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Siemens Showcases Multiple New IVD Solutions at AACC 2015

By LabMedica International staff writers
Posted on 28 Jul 2015
Siemens showcases a multidisciplinary portfolio of its latest in vitro diagnostic (IVD) workflow solutions and assays in one location—Booth 1409 at the 2015 AACC Meeting & Clinical Lab Expo (July 26–30; Atlanta, GA, USA).

Siemens Healthcare Diagnostics division of Siemens Healthcare (Erlangen, Germany) reveals its latest IVD solutions: in addition to featuring its portfolio of multidisciplinary solutions designed for use in hospital, reference, and physician office laboratories and near patients’ bedsides, the booth highlights how Siemens’ customers are achieving their clinical and workflow goals.

“Customers need a reliable partner who can help them achieve higher levels of operational efficiency while providing quality results that lead to optimal patient care,” said Michael Reitermann, CEO, Siemens Healthcare Diagnostics, “The solutions we are showcasing at this year’s AACC can help customers successfully achieve their workflow and clinical goals, regardless of the size of their operations or testing demands.”

One such example, the ADVIA Centaur XPT Immunoassay System1 is a high-throughput analyzer that enhances workflow to meet demands for reliable, rapid immunoassay testing. Recently FDA-cleared, this analyzer is designed to provide simple, continuous operation; accurate, timely results; and powerful, seamless connectivity including to Aptio Automation, the company’s flexible, track-based automation system.

Aptio Automation’s connectivity options include the ADVIA Chemistry XPT System—Siemens’ newest high-throughput chemistry analyzer, and the Sysmex CS-5100 System2 – a high-volume hemostasis analyzer. Siemens is the only single-source provider able to connect all four key laboratory disciplines—chemistry, immunoassay, hematology, and hemostasis—to the automation track.

Also at the booth is the Sysmex CS-2100i System2—a mid-volume benchtop hemostasis analyzer. Both the Sysmex CS-2100i System and Sysmex CS 5100 System utilize simultaneous multi-wavelength detection and first-to-market PSI technology to manage unsuitable coagulation samples (e.g., improperly filled sample tubes) for high-quality results.

Another new hemostasis offering on display—one for point-of-care (POC) testing—is the Xprecia Stride Coagulation Analyzer1. Winner of the Red Dot design award, this handheld system performs prothrombin time testing (PT/INR). In hematology, Siemens now offers to small and mid-sized laboratories the ADVIA 360 Hematology System3 ADVIA 560 Hematology System3 and ADVIA 560 AL Hematology System3 – they provide state-of-the-art testing capabilities and may be used as backup systems for larger labs.

The company’s leadership is also evidenced by its latest products in urinalysis, infectious disease and molecular testing, and customer education.

The CLINITEK AUWi PRO Automated Urinalysis System4 is a walkaway solution for integrated urinalysis testing. It combines a urine chemistry analyzer (CLINITEK Novus Automated Urine Chemistry Analyzer) with a urine sediment analyzer (Sysmex UF-1000i Automated Urine Particle Analyzer).

New infectious disease assays include the ADVIA Centaur HIV Ag/Ab Combo (C-HIV) assay, which allows for sensitive and specific detection of HIV p24 antigen and antibodies and may improve detection of early acute infections. The ADVIA Centaur Syphilis assay is used as a diagnostic aid, allowing for sensitive and specific detection of antibodies to Treponema pallidum in human serum or plasma (EDTA, lithium or sodium heparinized, sodium citrate).

In molecular testing, experts will be on hand to discuss the automated Siemens Tissue Preparation Solution, a reproducible and standardized process for the extraction of high-quality nucleic acid from formalin-fixed paraffin-embedded (FFPE) and fresh frozen (FF) tissues. It is enabling technology for the next generation of molecular diagnostics, including next-generation sequencing (NGS) for infectious disease and oncology testing.

Another innovative offering making its debut at AACC is Siemens PEPconnect, part of the total Personalized Education Plan (PEP)5, the industry’s first personalized learning and performance experience for healthcare professionals and their workgroup communities. With optimized technology and increased search capabilities, PEPconnect enables to access education and real-time performance support almost anytime, anywhere, and on almost any device, including smartphones.

At AACC, Siemens also offers educational workshops on chronic kidney disease and Centers for Disease Control (CDC) recommendations for syphilis and hepatitis C testing.

Related Links:

Siemens Healthcare at AACC 2015
Siemens Healthcare at AACC 2015, featured products
American Association for Clinical Chemistry (AACC)



Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.